Physiological levels of poly(ADP-ribose) during the cell cycle regulate HeLa cell proliferation.

Cell Cycle Cell Division HeLa Cells Humans NAD Poly (ADP-Ribose) Polymerase-1 / genetics Poly Adenosine Diphosphate Ribose / metabolism Poly(ADP-ribose) Polymerase Inhibitors / pharmacology Poly(ADP-ribose) Polymerases / genetics
ADP-Ribosylation Cell cycle Cell proliferation NAD(+) PolyADP-ribosylation S phase

Journal

Experimental cell research
ISSN: 1090-2422
Titre abrégé: Exp Cell Res
Pays: United States
ID NLM: 0373226

Informations de publication

Date de publication:
01 08 2022
Historique:
received: 20 11 2021
revised: 18 03 2022
accepted: 17 04 2022
pubmed: 22 4 2022
medline: 9 6 2022
entrez: 21 4 2022
Statut: ppublish

Résumé

Protein targets of polyADP-ribosylation undergo covalent modification with high-molecular-weight, branched poly(ADP-ribose) (PAR) of lengths up to 200 or more ADP-ribose residues derived from NAD

Identifiants

DOI: 10.1016/j.yexcr.2022.113163 PMID: 35447104 PMC: PMC10009817
pubmed: 35447104
pii: S0014-4827(22)00156-2
doi: 10.1016/j.yexcr.2022.113163
pmc: PMC10009817
mid: NIHMS1866687
pii:
doi:

Substances chimiques

Poly(ADP-ribose) Polymerase Inhibitors 0
NAD 0U46U6E8UK
Poly Adenosine Diphosphate Ribose 26656-46-2
Poly (ADP-Ribose) Polymerase-1 EC 2.4.2.30
Poly(ADP-ribose) Polymerases EC 2.4.2.30

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

113163

Subventions

Organisme : Intramural NIH HHS
ID : Z01 HL000659
Pays : United States

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Histochemie. 1966;6(4):370-81
pubmed: 5958929
J Biol Chem. 1971 Oct 25;246(20):6362-4
pubmed: 4331388
Nature. 2005 Apr 14;434(7035):913-7
pubmed: 15829966
Biochemistry. 2001 Sep 18;40(37):10947-55
pubmed: 11551189
J Biol Chem. 1979 May 10;254(9):3647-51
pubmed: 218977
J Med Chem. 2017 Feb 23;60(4):1262-1271
pubmed: 28001384
Exp Cell Res. 1983 Feb;143(2):377-82
pubmed: 6832224
J Biol Chem. 1986 May 25;261(15):7011-7
pubmed: 3084493
Mutat Res. 1989 Sep;218(2):67-74
pubmed: 2770765
PLoS Biol. 2008 Oct 14;6(10):e252
pubmed: 18922045
Proc Natl Acad Sci U S A. 1966 Nov;56(5):1535-42
pubmed: 5230312
Cancer Res. 2012 Nov 1;72(21):5588-99
pubmed: 23118055
Mol Cancer Ther. 2014 Feb;13(2):433-43
pubmed: 24356813
Sci Adv. 2019 Apr 10;5(4):eaav4340
pubmed: 30989114
Exp Cell Res. 2014 Nov 15;329(1):18-25
pubmed: 25017100
Anal Biochem. 1986 Feb 1;152(2):285-90
pubmed: 3008587
Cancer Cell. 2019 Mar 18;35(3):519-533.e8
pubmed: 30889383
Nucleic Acids Res. 2011 Apr;39(8):3166-75
pubmed: 21183466
Proc Natl Acad Sci U S A. 1982 Jun;79(11):3423-7
pubmed: 6808510
J Biol Chem. 1993 Jan 5;268(1):93-9
pubmed: 8416979
J Biol Chem. 1988 Mar 15;263(8):3879-83
pubmed: 3126180
Biochemistry. 1984 Jul 31;23(16):3771-7
pubmed: 6206890
Oncotarget. 2018 Jun 26;9(49):29140-29145
pubmed: 30018741
Bioessays. 2004 Aug;26(8):882-93
pubmed: 15273990
J Biol Chem. 1982 Nov 10;257(21):12872-7
pubmed: 6813330
Nature. 2005 Apr 14;434(7035):917-21
pubmed: 15829967
Science. 2003 Jan 24;299(5606):560-2
pubmed: 12543974
EMBO J. 1991 Dec;10(13):4351-60
pubmed: 1721870
Nat Commun. 2021 Jul 28;12(1):4581
pubmed: 34321462
Biochem Biophys Res Commun. 2016 Aug 5;476(4):594-599
pubmed: 27262441
Nat Rev Drug Discov. 2020 Oct;19(10):711-736
pubmed: 32884152
Cancer Res. 1973 Jun;33(6):1306-9
pubmed: 4352367
Nat Commun. 2019 Dec 11;10(1):5654
pubmed: 31827085
Biochem Biophys Res Commun. 1972 Jan 31;46(2):516-23
pubmed: 4333419
Trends Biochem Sci. 2019 Jun;44(6):490-501
pubmed: 30655165
Anal Biochem. 2016 Feb 1;494:76-81
pubmed: 26548958
Mol Cell. 2018 Jul 19;71(2):319-331.e3
pubmed: 29983321
Science. 1998 Nov 20;282(5393):1484-7
pubmed: 9822378
J Biol Chem. 2006 Jan 13;281(2):705-13
pubmed: 16278211
Mutat Res. 1981 Nov;84(1):125-32
pubmed: 7199115
J Biol Chem. 2002 Oct 18;277(42):39066-9
pubmed: 12205080
Arch Biochem Biophys. 1976 Aug;175(2):627-34
pubmed: 8713
Genes Dev. 1995 Mar 1;9(5):509-20
pubmed: 7698643
Nat Rev Cancer. 2013 Oct;13(10):714-26
pubmed: 24060863
Cell Cycle. 2004 Jul;3(7):941-5
pubmed: 15190204
Mutat Res. 1984 Mar;139(3):155-9
pubmed: 6422292
Biochemistry. 1996 Sep 10;35(36):11622-33
pubmed: 8794742
Cancer Cell. 2018 Jun 11;33(6):1078-1093.e12
pubmed: 29894693
J Biol Chem. 2007 Nov 2;282(44):32511-9
pubmed: 17827147
J Biol Chem. 1974 Jun 10;249(11):3475-82
pubmed: 4831224
J Biol Chem. 1987 Feb 15;262(5):2352-7
pubmed: 2434482
FEBS Lett. 1978 Jan 15;85(2):349-52
pubmed: 202502
J Biol Chem. 1999 Jun 18;274(25):17860-8
pubmed: 10364231
Exp Cell Res. 1993 May;206(1):43-8
pubmed: 8097727
Biochem Biophys Res Commun. 1971 Jun 18;43(6):1266-73
pubmed: 4328044
Cell. 2004 Dec 17;119(6):803-14
pubmed: 15607977
Biochem Biophys Res Commun. 1974 Jul 10;59(1):300-6
pubmed: 4210368
Mol Cell. 2007 Jan 26;25(2):297-308
pubmed: 17244536
N Engl J Med. 2017 Aug 10;377(6):523-533
pubmed: 28578601
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17079-84
pubmed: 18971340
Mutat Res. 1987 May;191(1):29-35
pubmed: 2952875
Nat Commun. 2013;4:2993
pubmed: 24356582
J Biol Chem. 1980 Nov 10;255(21):10502-8
pubmed: 6253477
ACS Chem Biol. 2013 Jul 19;8(7):1567-75
pubmed: 23631432
Cell Cycle. 2016 Aug 2;15(15):2042-52
pubmed: 27295004
Nature. 1980 Feb 7;283(5747):593-6
pubmed: 6243744
J Biochem. 1975 Jan 1;77(1?):5p-6p
pubmed: 805788
Nucleic Acids Res. 1998 Apr 15;26(8):1891-8
pubmed: 9518481
Biochemistry. 1976 Mar 23;15(6):1213-7
pubmed: 175834
Exp Cell Res. 1978 Nov;117(1):127-35
pubmed: 363436
Nature. 1976 Feb 26;259(5545):695-6
pubmed: 175293
Cancer Res. 1984 Jun;44(6):2485-92
pubmed: 6233001
Cancer Res. 1997 Mar 1;57(5):803-7
pubmed: 9041174
Nature. 1979 Dec 13;282(5740):740-1
pubmed: 229416
J Biol Chem. 1982 Jun 10;257(11):6565-70
pubmed: 7042716
ACS Chem Biol. 2016 Nov 18;11(11):3179-3190
pubmed: 27689388
Cancer Sci. 2012 Feb;103(2):191-6
pubmed: 22085410
NMR Biomed. 2008 Feb;21(2):159-64
pubmed: 17461436
Arch Biochem Biophys. 1971 Oct;146(2):579-86
pubmed: 5114920
Biochemistry. 1973 Aug 14;12(17):3303-8
pubmed: 4354607
J Biol Chem. 2006 Nov 3;281(44):33363-72
pubmed: 16931513

Auteurs

Sachiko Yamashita (S)

Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan.

Masakazu Tanaka (M)

Joint Research Center for Human Retrovirus Infection, Kagoshima University, Sakuragaoka 8-35-1, Kagoshima, 890-8544, Japan.

Chieri Ida (C)

Department of Applied Life Sciences, College of Nagoya Women's University, Nagoya-shi, Aichi, 467-8610, Japan.

Kenichi Kouyama (K)

Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan.

Setsu Nakae (S)

Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan.

Taisuke Matsuki (T)

Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan.

Masataka Tsuda (M)

Program of Mathematical and Life Sciences, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, 739-8526, Japan.

Tsuyoshi Shirai (T)

Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan.

Kazuo Kamemura (K)

Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan.

Yoshisuke Nishi (Y)

Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan.

Joel Moss (J)

Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 20892-1590, USA.

Masanao Miwa (M)

Faculty of Bioscience, Nagahama Institute of Bio-Science and Technology, Nagahama, Shiga, 526-0829, Japan. Electronic address: m_miwa@nagahama-i-bio.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes physiologiques cellulaires › Cycle cellulaire › Physiological levels of poly(ADP-ribose)...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Processus de croissance cellulaire › Prolifération cellulaire › Division cellulaire › Physiological levels of poly(ADP-ribose)...
questionsmedicales.fr › Cellules › Cellules épithéliales › Cellules HeLa › Physiological levels of poly(ADP-ribose)...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Physiological levels of poly(ADP-ribose)...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Nucléotides › Ribonucléotides › Nucléotides adényliques › NAD › Physiological levels of poly(ADP-ribose)...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Transferases › Glycosyltransferase › Pentosyltransferases › ADP ribose transferases › Poly(ADP-ribose) polymerases › Poly (ADP-Ribose) polymerase-1 › Physiological levels of poly(ADP-ribose)...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Nucléotides › Ribonucléotides › Nucléoside diphosphate ose › Adénosine diphosphate ose › Adénosine diphosphate ribose › Poly adénosine diphosphate ribose › Physiological levels of poly(ADP-ribose)...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Inhibiteurs de poly(ADP-ribose) polymérases › Physiological levels of poly(ADP-ribose)...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Transferases › Glycosyltransferase › Pentosyltransferases › ADP ribose transferases › Poly(ADP-ribose) polymerases › Physiological levels of poly(ADP-ribose)...